Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Vietnam flag Vietnam · Delayed Price · Currency is VND
50,000
+100 (0.20%)
At close: Feb 27, 2026
44.93%
Market Cap 1.10T
Revenue (ttm) 950.89B
Net Income (ttm) 63.81B
Shares Out 22.08M
EPS (ttm) 2,889.37
PE Ratio 17.30
Forward PE n/a
Dividend 1,500.00 (3.00%)
Ex-Dividend Date Mar 19, 2025
Volume 601
Average Volume 831
Open 49,900
Previous Close 49,900
Day's Range 49,900 - 50,000
52-Week Range 33,000 - 58,000
Beta 0.10
RSI 55.93
Earnings Date Mar 26, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamin, minerals, antiseptics, and others. The company also engages in hotel and real estate business; and provision of drug storage and testing, and technology transfer consulting servi... [Read more]

Industry Pharmaceutical Preparations
Founded 2003
Employees 195
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol VDP
Full Company Profile

Financial Performance

In 2025, HOSE:VDP's revenue was 950.89 billion, an increase of 1.76% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.

Financial Statements

News

There is no news available yet.